INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
Clinical trial NCT03037164 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03037164
- Sponsor
- Cerus Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2026-07-31
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.